Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
MMs letting it go! Very strong finish on the cards.
Up 21%. Ticked up again.
Bantham. You only seem to have negative thoughts! The sp is telling us things are picking up BIGTIME. The sp was a tad below 10p last November. It's now 16.75p. More than 50% more. The contracts have only just started to arrive. LOADS to come IMHO.
All IMHO.
So you don’t think they will raise?m The company have told you that even if they make £6.6m this year in revenue they will have zero cash by end Q2. So one thing is certain - they need a lot of cash. If it all comes from customers - great. But no signs of that yet.
Up 20% now.
Just ticked up.
Wow. Don't see that very often!
Bantham. That statement is ridiculous. For example. Angle are looking for a Pharma partner to join them and Bioview to market the HER2 system Bioview and Angle have spent just over a year developing. An up front payment to become that partner could be in the milions. Just one example. We know they talk to Eisai and Astrazeneca already......
You are so quick to look on the bad side!
All IMHO.
EC - not a cat in he11’s chance there’s no raise by Q1 25.
But if he can build some belief ahead of it - then maybe it won’t be sp destructive as i feared……
Better than expected job figures in USA. Dow futures now up 500pts
Landing a half million £ contract with Astrazeneca might be better appreciated by the yanks!
Bantham.
It's 4th May 2024. Angle cash runway WAS until 1st quarter 2025. It is possible a cash raise won't be necessary. Mr Newland in the interview said they are talking to "11 other possible customers, 6 are "household" names"..........
Bound to be additional contracts from Eisai and Astrazeneca too IMHO.........
8 months to land more contracts. It's easily doable now.
All IMHO.
Watch the January presentation available on YouTube. Cash runway till 2025
FEVERTREEMAN. - i have bought some today. I have done this several times and always regretted it given the hype and nonsense from Newland. But maybe we are seeing something here.
But let’s not forget - there is a fundraise at some stage.
So i would urge people not to get too over-excited ( I’ve already seen crazy ramping this morning by people who know zero about this situation )
HZM up 16%,, leaky
After the FIRST Astrazeneca contract on 24th April.....
THIS TIME I THINK 20P PLUS.
USA interest..........
aLL imho!!!
I see you have the serial ramper over here now
PRICK123 ramps and pumps every blue board
🔔end
Revising my post from earlier with the figures used by AN in the interview (which were much larger than my estimates)
For every assay that Angle develop:-
- the assay development fees will be low ($250k - $750k depending on complexity)
- following the assay development there should be multiple phase 1/2 trial contracts, with multiple pharma, with higher value (£1m-£4m depending on number of patients / tests per patient)
- a number of the P1/2 trials will be followed with P3 trials, the contracts for which will be larger still (£15m-£45m))
- and finally this may lead to the assay / parsortix being used as a companion diagnostic (Cdx) which will deliver significant annual revenue (£20-£100m per annum)
So the key message is THESE ASSAY CONTRACTS are critical as they open the gates to the high volume downstream cashflow. As my brother (who has worked in biotech sales or over 24 years) said when the last contract was announced, "where one large pharma goes the others will quickly follow as nobody wants to be left at a disadvantage".
Think there's more to the HZM story than meets the eye.... Up 13%. could 300 x bag on the right news
Will top 20p a share TODAY IMHO!!!!!!!!!!!!! Listen to this!!!!:-
https://www.proactiveinvestors.co.uk/companies/news/1046802/angle-announces-second-assay-with-astrazeneca-as-it-deepens-relationship-with-pharma-giant-1046802.html
holy *****!!!!
"astra have 460 active cance trials with 140,000 patients involved.".
halo effect.... knock on impact. pipeline of 11 other possible customers, 6 are "household" names!!!!!!!>>
https://www.proactiveinvestors.co.uk/companies/news/1046802/angle-announces-second-assay-with-astrazeneca-as-it-deepens-relationship-with-pharma-giant-1046802.html
Parsortix has FDA approval for medical use in the USA for Breast cancer. There is a massive world wide market for this alone. Massive.
Even more massive IMHO it can be used for ***ANY cancer during a cancer drug trial***. There is £ millions to be made from Parsortix being used during drug trials. The RNS of 4th Jan IS THE MOST SIGNIFICANT ANNOUNEMENT AGL HAVE MADE EVER IMHO. It shows with the dual CtDNA and CTC analysis a cancer that has matastacised can be MONITORED to find out HOW THE NEW DRUG IS PERFORMING !!!!!!!!! Before. DURING and AFTER treatment!!!!
https://www.lse.co.uk/rns/AGL/breakthrough-clinical-results-b0km788ah9aflqm.html
All IMHO.
I expect, apart from the cash, the publicity and the downstream contract potential of this, one of the advantages is that it facilitates FDA approval.
Sp peaked around 13:45 @ 17p bid After the FIRST Astrazeneca contract on 24th April.....
Going up again after a little breather
Hello.